The four finalists in the BIPOC-Founded Business category for the inaugural InnovationMap Awards share their best advice for their fellow founders. Photos courtesy
Keep reading...Show less
This week's roundup of Houston innovators includes Sameer Soleja of Molecule, Gabriela Gerhart of The Motherhood center, and 50 Cent. Courtesy photos

3 Houston innovators to know this week

who's who

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — software, education, and more — recently making headlines in Houston innovation.

Sameer Soleja, CEO of Molecule

Sameer Soleja, CEO of Molecule, joins the Houston Innovators Podcast to discuss his startup's recent fundraise — and how he's planning on being at the forefront of the evolving electricity commodities industry. Photo courtesy of Molecule

A 9-year-old software startup has been reinvigorated by fresh funds and a new opportunity to emerge as a leader in enterprise software for commodities — especially for electricity traders. Sameer Soleja, CEO of Molecule, joins the Houston Innovators Podcast to discuss the company's latest funding round — a $12 million series A.

"The commodities industry is looking really hard at electricity as the growth commodity of the 2020s — renewables and conventionally generated electricity," Soleja says. "Everybody in our client base and in the market is looking at electricity. Well, we happen to have more than have of our customer base be in electricity."

Click here to listen to the podcast and read more.

Gabriela Gerhart, founder of The Motherhood Center

Houston entrepreneur recounts journey from communism to U.S. success in new book

Gabriela Gerhart recounts her journey from communism to American success in her new book. Photo courtesy of Gabriela Gerhart

Gabriela Gerhart remembers that day, back in 1989, when her teacher walked into her classroom in Czechoslovakia and announced that communism was over. Further, she told the group that everything she'd been teaching them was a lie.

Gerhart was stunned.

"It was confusing," she tells CultureMap. "You think to yourself, 'was I fooled? Was I indoctrinated? 'You have to understand, I had no idea there was another world out there."

Gerhart, founder of The Motherhood Center on West Alabama Street unpacks those feelings and others in her new autobiography, After The Fall, a story of growing up in Central Europe under communism and following her own wanderlust to the States, where she fell in love, got married, and built a successful business.

Click here to read more.

Rapper 50 Cent really means business. 50 Cent/Twitter

Rap star and Newstonian 50 Cent is giving back to area schools in need of help. The recently relocated rapper/producer/entrepreneur/rodeo wine bidder is teaming up with the Houston Independent School District and Horizon United Group to bolster entrepreneurship programs at Kashmere, Worthing, and Wheatley high schools.

He has funded the project with a $600,000 donation, Mayor Sylvester Turner announced on May 17.

Dubbed the G-Unity Business Lab, the new program will encourage students to engage in MBA-level lessons that represent the full lifecycle of a product or concept, from idea creation, to market branding, to even running a company, a press release notes.

Click here to read more.

Sameer Soleja, CEO of Molecule, joins the Houston Innovators Podcast to discuss his startup's recent fundraise — and how he's planning on being at the forefront of the evolving electricity commodities industry. Photo courtesy of Molecule

Houston software startup to use fresh funds to become 'unquestionably the best' for the electricity industry

HOUSTON INNOVATORS PODCAST EPISODE 84

Sameer Soleja went to business school and came back into the workforce with a bit of a revelation about software for the commodities industry.

"I realized, 'wait a second, we've been making terrible software and selling it for tens of millions of dollars," Soleja, CEO of Molecule, says on this week's episode of the Houston Innovators Podcast. "We had to be able to do something better than this — technology is better than this."

Soleja founded Molecule in 2012 to address the problem. The technology isn't unfamiliar to what ardent stock traders have at their fingertips, but before these types of platforms came into the picture, commodities companies didn't have a central platform.

"The way to think about the product is if you have a brokerage account — like Robinhood, or something like that — you see how much stock you have and how much you've made or lost," Soleja says. "For companies that are trading electricity, crude oil, natural gas, and other commodities and agricultural products, they also want to see how much of each thing they have and how much they've made or lost. But they don't just get to log into their brokerage account and figure it out. That's in a lot of different places."

Lately, a couple companies have bought up some of the businesses in this sector, leaving a lot of room open up at the top. Soleja says he saw this as an opportunity and started the arduous fundraising process. Molecule closed its series A round led by Houston-based Mercury Fund this month.

The other opportunity Soleja says he saw was a new market focus on electricity — a subsector Molecule is very good at working with. About half of Molecule's clients are in this field and electricity — as opposed to oil and gas products — is full of data. Where data comes in weekly or even monthly for O&G, fresh data comes in every 15 minutes for Molecule's electrical clients.

"The commodities industry is looking really hard at electricity as the growth commodity of the 2020s — renewables and conventionally generated electricity," Soleja says. "Everybody in our client base and in the market is looking at electricity. Well, we happen to have more than have of our customer base be in electricity."

Therein lies the opportunity for Molecule, which is also interested in deploying its capital is into engineering to both meet the feature gap and exceed in places where the company is already better, Soleja explains.

"We realized, well that's the place we double down because that's where the economy is going and that's what we're good at. Let's become unquestionably the best at it," he says.

The funds will go toward company expansion. Soleja says he plans to add 50 percent to his team within the next 6 to 12 months and potentially be at 30 to 40 people in a year or two from now. Over the past nine years, Molecule has been growing organically without a centralized focus on sales and marketing.

"We are way below the benchmark for what everyone else spends on sales and marketing. So, we're going to fix that," he says.

Soleja shares more about his raise process and shares advice for his fellow startup founders on the episode. Listen to the full interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.

Molecule has closed new funding in order to focus on the energy transition. Photo via Getty Images

Houston SaaS startup closes $12M series A funding round with support from local VC

money moves

A Houston startup with a software-as-a-service platform for the energy transition has announced it closed a funding round with participation from a local venture capital.

Molecule closed its $12 million series A, and Houston-based Mercury Fund was among the company's investors. The company has a cloud-based energy trading and risk management solution for the energy industry and supports power, natural gas, crude/refined products, chemicals, agricultural commodities, softs, metals, cryptocurrencies, and more.

"We led the seed round of Molecule upon their formation and are excited to participate in their series A," says Blair Garrou, co-founder and managing director of Mercury, in a news release. "Molecule's success in the ETRM/CTRM industry, especially in relation to electricity and renewables, positions them as the company to beat for the energy transition in the 2020s."

The company will use its new funds to further build out its product as well as introduce offerings to manage renewables credits, according to the release.

"In 2020, we realized that electricity — the growth commodity of the 2020s — represented over half of Molecule's customer base, and we decided to double down," says Sameer Soleja, founder and CEO of Molecule, in the release. "We were also rated the No. 1 SaaS ETRM/CTRM vendor. With this fundraise, we have the fuel to become No. 1 SaaS platform for power and renewables, and then the market leader overall.

"Molecule is ready to power the energy transition," Soleja continues.

Molecule's last round of funding closed in November 2014. The $1.1 million seed round was supported by Mercury Fund and the Houston Angel Network.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC names inaugural cohort for unique accelerator with UK

coming to HOU

Sixteen digital health and medical device startups founded in the United Kingdom have been selected for a customized accelerator at the Texas Medical Center's Innovation Factory.

In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.

“The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries," says Ashley McPhail, chief external affairs and administration officer for TMC, in a news release. "We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator."

The 16 companies will participate in the program from June to November. The cohort is expected to arrive in Houston on June 5 and have access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US. The new offering joins three other globally recognized curriculums: Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

“TMCi nurtures long-term growth, development, and competitiveness to increase startups chances of success and global expansion," says Emily Reiser, associate director of TMC Innovation. "By bringing their novel technologies and exposing them to a curated selection of TMC’s expert network, startups receive support and evaluation to build, scale, and expand in the US market."

Two of the cohort's specialties include cardiovascular and oncology — two of TMC's strongest areas of expertise — with solutions ranging from surgical devices to AI-enabled risk stratification and hospital efficiency.

Innovate UK is the country's national innovation agency dedicated to supporting business-led innovation in all sectors.

“The United Kingdom is fully committed to improving global healthcare through scientific collaboration," says His Majesty’s Consul General in Texas Richard Hyde in the release. "Through the expansion of the TMC UK BioBridge and in partnership with Innovate UK, this programme will help to expose the brightest and best British companies to the world’s largest medical city. Our companies will collaborate and grow as they work to develop cutting edge technology. The partnership between the UK Government and TMC demonstrates that international collaboration can drive both economic growth and improvement to quality of life.”

The 16 companies making up the inaugural cohort are as follows, according to TMC.

  • AINOSTICS aims to revolutionize the treatment and prevention of neurological conditions, such as dementia, by developing innovative AI-enabled solutions that draw novel insights from routinely acquired non-invasive medical scans to deliver accurate diagnosis and outcome prediction, and in turn facilitate personalized care and timely access to disease-modifying treatments for patients.
  • Alvie is a blended human plus AI-enabled digital solution providing personalised pre and rehabilitation coaching and supportive care for cancer and surgery. Alvie's technology combines data profiling, risk-stratification and tailored prescriptions of health and well-being with curated educational content, targeted behaviour change coaching and expert support through chat messaging and virtual consultations.
  • C the Signs™ is a validated AI cancer prediction platform, which can identify patients at risk of cancer at the earliest and most curable stage of the disease. Used by healthcare professionals, C the Signs can identify which tumor type a patient is at risk of and recommend the most appropriate next step in less than 30 seconds. The platform has detected over 10,000 patients with cancer, with over 50 different types of cancer diagnosed, and with a sensitivity of >98% for cancer.
  • At PEP Health, We believe all patients deserve the best care possible. Our cutting-edge machine-learning technology enables healthcare organisations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
  • PreciousMD improves the lives of lung-cancer and other lung-related illnesses patients worldwide by enabling imaging-based diagnostics needed for personalized treatment pathways.
  • Ufonia is an autonomous telemedicine company, we use large language models and voice AI to increase the capacity of clinical professionals.
  • My mhealth offers digital therapeutics for a range of long-term conditions- COPD, Asthma, Diabetes and Heart Disease. Our product has been successfully deployed in the UK and India, with >100,000 users registered to date. Our solutions empower patients to self-manage their conditions, resulting in dramatic improvements in outcomes, as evidenced through multiple clinical trials and real-world evaluations.
  • At Surgery Hero, we offer a clinically backed solution that ensures whole-human support before and after surgery. We help health systems, employers and health plans cut costs without sacrificing quality of care.
  • Panakeia's software platform enables extremely rapid multi-omics profiling in minutes directly from routinely used tissue images without needing wet lab assays.
  • QV Bioelectronics are striving to deliver longer, better quality lives for brain tumour patients. Using their first-of-its-kind implantable electric field therapy device, GRACE, QV will provide effective, focal & continuous treatment without impacting patient quality of life.
  • 52 North is a med-tech company focused on improving health outcomes and health equity by reinventing care pathways. The NeutroCheck® solution is a finger-prick blood test and digital platform built to significantly improve safety and quality of life for cancer patients, by helping to identify at-home those patients who are at risk of the most fatal side-effect of chemotherapy: neutropenic sepsis.
  • Somnus is fulfilling an unmet need in global healthcare by developing real-time, point of care blood propofol monitoring. Its products will improve the care of sedated and anaesthetised patients, save money for hospitals, and facilitate a major reduction in greenhouse gas emissions.
  • ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for cost-efficient and longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs.
  • IBEX is on a mission to help people live active, healthy and productive lives by increasing their access to early diagnosis of osteoporosis. The IBEX BH software as medical device delvers routine, automated assessment of fracture risk from routine radiology for earlier detection and more equitable treatment of osteoporosis.
  • NuVision produces products derived from donated human amniotic membrane that are used in ophthalmology to help patients with chronic, traumatic and post-surgical wounds of the eye to be treated earlier and recover more fully and more quickly. The company’s products are also used in the management of dry eye disease, a debilitating conditions that affects around 17m people in the USA.
  • Calon Cardio-Technology is on a mission to improve quality of life for patients with Left Ventricular Assist devices (LVAD) and reduce the common post operative complications associated with these implantable heart pumps. We plan to do this by introducing a completely wireless heart pump system and augment patient follow-up with built-in remote monitoring capabilities.

UH lab using mixed reality to optimize designs for the Moon and Mars

hi, tech

University of Houston researchers and students are bringing multiple realities together to help improve the design process for crewed space missions.

Helmed by Vittorio Netti, a researcher for UH and a space architect, the university has launched an XR Lab within the University of Houston architecture building. The lab allows researchers to combine mixed reality (MR), virtual reality (VR), augmented reality (AR) and extended reality (XR) to "blend the physical and digital worlds" to give designers a better understanding of life in space, according to a release from UH.

In the lab researchers can wear MY space suits and goggles, take a VR space walk, or feel what it's like to float to the International Space Station with the help of XR and a crane.

The area in which the researchers conduct this work is known as the "cage" and was developed during a six-month research and design study of lunar surface architecture sponsored by Boeing, which aimed to learn more about the design of a lunar terrain vehicle and a small lunar habitat.

The work is part of UH's Sasakawa International Center of Space Architecture (SICSA), which is led by Olga Bannova, a research associate professor and director of the space architecture graduate program at UH.

She says work like this will drastically cut down research and development time when designing space structures.

“These technologies should be harnessed to mitigate the dependency on physical prototyping of assets and help optimize the design process, drastically reducing research-and-development time and providing a higher level of immersion,” Bannova said in a statement.

Today the research team is shifting its focus on designing for a Mars landing. In the future, they aim to demonstrate and test the system for habitats designed for both lunar and Martian surfaces. They are also working with Boeing to test designs in microgravity, or zero gravity, which exists inside the International Space Station.

Mixed Reality Raising the Bar for Space Architecture on the Moon and MarsStep into this 'Cage' at the University of Houston where physical and digital worlds are merged, allowing students to see and ...